Skip to main content

MYLAN 143 MYLAN 143 Pill - green capsule/oblong, 14mm

Pill with imprint MYLAN 143 MYLAN 143 is Green, Capsule/Oblong and has been identified as Indomethacin 25 mg. It is supplied by Mylan Pharmaceuticals Inc.

Indomethacin is used in the treatment of Ankylosing Spondylitis; Back Pain; Bursitis; Bartter Syndrome; Cluster Headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 143 MYLAN 143

Indomethacin 25 mg MYLAN 143 MYLAN 143
Indomethacin 25 mg MYLAN 143 MYLAN 143 Front
Indomethacin 25 mg MYLAN 143 MYLAN 143 Back
Indomethacin 25 mg MYLAN 143 MYLAN 143


25 mg
14.00 mm
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, gelatin, FD&C Green No. 3, magnesium stearate, microcrystalline cellulose, cellulose powdered, sodium lauryl sulfate, sodium starch glycolate type A potato, titanium dioxide, D&C Yellow No. 10, ferrosoferric oxide, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0143 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0190 (Discontinued) UDL Laboratories Inc.
54569-0277 (Discontinued) A-S Medication Solutions, LLC (repackager)
66267-0119 (Discontinued) Nucare Pharmaceuticals Inc. (repackager)
54569-4123 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Related images for "MYLAN 143 MYLAN 143"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.